Cortisol suppression index in major depressive illness.

Area of Science:

• Endocrinology
• Psychiatry
• Clinical Diagnostics

Background:

• Major depressive disorder (MDD) diagnosis relies on clinical assessment and can be aided by biological markers.
• The dexamethasone suppression test (DST) is a commonly used test, but has limitations.
• Cortisol dysregulation is implicated in MDD pathophysiology.

Purpose of the Study:

• To compare the diagnostic utility of a novel cortisol suppression index (CSI) against the standard dexamethasone suppression test (DST).
• To evaluate the sensitivity, specificity, and diagnostic confidence of the CSI in patients with major depressive disorder.

Main Methods:

• A study involving 50 patients diagnosed with major depressive disorder.
• Comparison of diagnostic performance metrics between the cortisol suppression index and the standard dexamethasone suppression test.
• Assessment of sensitivity, specificity, and diagnostic confidence for both methods.

Main Results:

• The cortisol suppression index demonstrated comparable sensitivity to the dexamethasone suppression test.
• The cortisol suppression index exhibited superior specificity compared to the dexamethasone suppression test.
• Greater diagnostic confidence was reported with the cortisol suppression index.

Conclusions:

• The cortisol suppression index serves as a potentially valuable diagnostic aid for major depressive disorder.
• The CSI offers improved specificity and diagnostic confidence over the DST.
• Eliminating the need for late-evening blood samples makes the CSI a more practical and acceptable alternative diagnostic procedure.